These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings
Nov 14, 2025, 12:01 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Despite beating loss estimates, missed sales targets and a significant drop in stock price suggest negative investor sentiment. Historical examples show that mixed earnings can lead to long-term bearish trends.
AI summary
What happened, with direct paths to the underlying reporting
TELA reported Q3 losses of 19 cents, better than expected. Quarterly sales of $20.7 million missed analysts' expectations. CEO claims progress from improved leadership and strategic changes. Shares fell 13.7% post-earnings to $0.96. Analysts adjusted price targets downward; mixed ratings issued.
TELA reported Q3 losses of 19 cents, better than expected.
Quarterly sales of $20.7 million missed analysts' expectations.
CEO claims progress from improved leadership and strategic changes.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
TELA Bio reported mixed fourth-quarter results with losses better than expected, but sales missed estimates, leading to lowered first-quarter projections. Analysts have subsequent…